NO20065582L - (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer - Google Patents

(1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer

Info

Publication number: NO20065582L
Authority: NO; Norway
Prior art keywords: benzoxazin; pyrazolo; aminocarbonyl; dihydro; phenyl
Prior art date: 2004-05-04

Application number

NO20065582A

Other languages

English (en)

Norwegian (no)

Inventor

Dominique Louis Nest Surleraux

Abdellah Tahri

Lieve Emma Jan Michiels

Koenraad Lodewijk August Acker

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-04

Filing date

2006-12-04

Publication date

2006-12-04

2006-12-04 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2006-12-04 Publication of NO20065582L publication Critical patent/NO20065582L/no

Links

-1 aminocarbonyl-phenyl Chemical group 0.000 title abstract 3
239000003112 inhibitor Substances 0.000 title abstract 3
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical class O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 title abstract 2
230000029812 viral genome replication Effects 0.000 title abstract 2
241000725303 Human immunodeficiency virus Species 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
208000030507 AIDS Diseases 0.000 abstract 1
238000009007 Diagnostic Kit Methods 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20065582A 2004-05-04 2006-12-04 (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer NO20065582L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04101913		2004-05-04
US60427504P	2004-08-25	2004-08-25
PCT/EP2005/052041 WO2005105810A2 (en)	2004-05-04	2005-05-04	(1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors

Publications (1)

Publication Number	Publication Date
NO20065582L true NO20065582L (no)	2006-12-04

Family

ID=35058129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065582A NO20065582L (no)	2004-05-04	2006-12-04	(1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer

Country Status (20)

Country	Link
US (1)	US7326703B2 (pl)
EP (1)	EP1778696B1 (pl)
JP (1)	JP4929162B2 (pl)
KR (1)	KR20070015547A (pl)
CN (1)	CN1950380B (pl)
AP (1)	AP2006003759A0 (pl)
AR (1)	AR048650A1 (pl)
AT (1)	ATE389660T1 (pl)
AU (1)	AU2005238235B2 (pl)
BR (1)	BRPI0510612A (pl)
CA (1)	CA2563959C (pl)
DE (1)	DE602005005490T2 (pl)
ES (1)	ES2303244T3 (pl)
IL (1)	IL178082A (pl)
MX (1)	MXPA06012755A (pl)
NO (1)	NO20065582L (pl)
PL (1)	PL1778696T3 (pl)
RU (1)	RU2382789C2 (pl)
WO (1)	WO2005105810A2 (pl)
ZA (1)	ZA200609178B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7122185B2 (en)	2002-02-22	2006-10-17	Progenics Pharmaceuticals, Inc.	Anti-CCR5 antibody
TW200710091A (en) *	2005-04-11	2007-03-16	Tibotec Pharm Ltd	(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
CA2616189C (en) *	2005-07-22	2019-03-26	Progenics Pharmaceuticals, Inc.	Methods for reducing viral load in hiv-1-infected patients
JP2010531301A (ja) *	2007-06-25	2010-09-24	テイボテク・フアーマシユーチカルズ	ダルナビル及びエトラビリンを含んでなる組み合わせ調剤
US8592487B2 (en) *	2007-10-26	2013-11-26	Concert Pharmaceuticals, Inc.	Deuterated darunavir
WO2009134401A2 (en) *	2008-04-29	2009-11-05	Progenics Pharmaceuticals, Inc.	Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
DE4210939A1 (de) *	1992-04-02	1993-10-07	Bayer Ag	Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
IL106507A (en) *	1992-08-07	1997-11-20	Merck & Co Inc	Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
PH30929A (en)	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
PT721331E (pt)	1993-10-01	2002-05-31	Astrazeneca Ab	Processo i
WO1997044014A1 (en)	1996-05-20	1997-11-27	Janssen Pharmaceutica N.V.	Antifungal compositions with improved bioavailability
ES2203790T3 (es) *	1996-10-02	2004-04-16	Bristol-Myers Squibb Pharma Company	1,4-dihidro-2h-3,1-benzoxacin-2-onas 4,4-disustituidas utiles como inhibidores de la transcriptasa reversa del hiv e intermedios y procedimientos para su preparacion.
SK284813B6 (sk)	1997-03-26	2005-12-01	Janssen Pharmaceutica N. V.	Peleta obsahujúca itrakonazol, spôsob jej prípravy a farmaceutická dávková forma s jej obsahom
BR9815899A (pt) *	1998-05-20	2001-02-20	Lilly Co Eli	Compostos antivirais
IL157875A0 (en) *	2001-04-10	2004-03-28	Pfizer	Pyrazole derivatives for treating hiv

2005
- 2005-05-03 AR ARP050101767A patent/AR048650A1/es unknown
- 2005-05-04 WO PCT/EP2005/052041 patent/WO2005105810A2/en not_active Ceased
- 2005-05-04 PL PL05740229T patent/PL1778696T3/pl unknown
- 2005-05-04 AU AU2005238235A patent/AU2005238235B2/en not_active Ceased
- 2005-05-04 ES ES05740229T patent/ES2303244T3/es not_active Expired - Lifetime
- 2005-05-04 DE DE602005005490T patent/DE602005005490T2/de not_active Expired - Lifetime
- 2005-05-04 JP JP2007512194A patent/JP4929162B2/ja not_active Expired - Fee Related
- 2005-05-04 RU RU2006142705/04A patent/RU2382789C2/ru not_active IP Right Cessation
- 2005-05-04 US US11/568,380 patent/US7326703B2/en not_active Expired - Fee Related
- 2005-05-04 CA CA2563959A patent/CA2563959C/en not_active Expired - Fee Related
- 2005-05-04 BR BRPI0510612-5A patent/BRPI0510612A/pt not_active IP Right Cessation
- 2005-05-04 AT AT05740229T patent/ATE389660T1/de not_active IP Right Cessation
- 2005-05-04 MX MXPA06012755A patent/MXPA06012755A/es active IP Right Grant
- 2005-05-04 KR KR1020067022005A patent/KR20070015547A/ko not_active Withdrawn
- 2005-05-04 CN CN2005800140097A patent/CN1950380B/zh not_active Expired - Fee Related
- 2005-05-04 EP EP05740229A patent/EP1778696B1/en not_active Expired - Lifetime
- 2005-05-04 AP AP2006003759A patent/AP2006003759A0/xx unknown
2006
- 2006-09-14 IL IL178082A patent/IL178082A/en not_active IP Right Cessation
- 2006-11-03 ZA ZA200609178A patent/ZA200609178B/xx unknown
- 2006-12-04 NO NO20065582A patent/NO20065582L/no unknown

Also Published As

Publication number	Publication date
CN1950380A (zh)	2007-04-18
ATE389660T1 (de)	2008-04-15
JP4929162B2 (ja)	2012-05-09
AP2006003759A0 (en)	2006-10-31
DE602005005490T2 (de)	2009-04-23
ES2303244T3 (es)	2008-08-01
EP1778696A2 (en)	2007-05-02
US20070248624A1 (en)	2007-10-25
RU2382789C2 (ru)	2010-02-27
JP2007536346A (ja)	2007-12-13
AU2005238235B2 (en)	2011-07-07
DE602005005490D1 (de)	2008-04-30
BRPI0510612A (pt)	2007-10-30
CN1950380B (zh)	2010-12-08
IL178082A0 (en)	2006-12-31
EP1778696B1 (en)	2008-03-19
CA2563959A1 (en)	2005-11-10
AU2005238235A1 (en)	2005-11-10
MXPA06012755A (es)	2007-01-16
IL178082A (en)	2012-06-28
KR20070015547A (ko)	2007-02-05
AR048650A1 (es)	2006-05-10
ZA200609178B (en)	2008-08-27
WO2005105810A2 (en)	2005-11-10
CA2563959C (en)	2014-07-15
PL1778696T3 (pl)	2008-08-29
RU2006142705A (ru)	2008-06-20
WO2005105810A3 (en)	2006-03-02
US7326703B2 (en)	2008-02-05

Similar Documents

Publication	Publication Date	Title
NO20072235L (no)	2007-06-28	HCV-hemmende bicykliske pyrimidiner
HK1049150A1 (zh)	2003-05-02	用作hiv逆转录酶抑制剂的稠合1，5-二氮杂萘
ATE552261T1 (de)	2012-04-15	Pyrazol-ä1,5-aü pyrimidine als proteinkinasehemmer
MY146669A (en)	2012-09-14	Pyrazole derivatives for treating hiv
TW200612898A (en)	2006-05-01	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
NO20082530L (no)	2008-08-07	Imidazopyraziner som proteinkinaseinhibitorer
WO2003105770A3 (en)	2004-10-07	Carbocyclic nucleoside analogs as rna-antivirals
NO20073140L (no)	2007-06-20	Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20085176L (no)	2009-01-28	Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter
NO20082092L (no)	2008-07-04	Pyrazolopyrimidiner som proteinkinaseinhibitorer
BRPI0408704A (pt)	2006-03-07	benzil-piridazinonas como inibidores de transcriptase reversa
ATE494373T2 (de)	2011-01-15	Verfahren und zusammensetzungen zur verringerung von hcv virusgenommengen in einer zielzelle
BRPI0511982A (pt)	2008-01-22	compostos antiviróticos heterocìclicos
WO2005041951A3 (en)	2005-10-06	Rhodanine derivatives for use as antiviral agents
BRPI0414948A (pt)	2006-11-07	derivados de pirazolo-e-imidazo pirimidina
YU62504A (sh)	2006-08-17	Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
WO2004002410A3 (en)	2004-08-05	2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
MXPA04004621A (es)	2004-09-10	Nucleotidos, preparaciones de los mismos y su utilizacion como inhibidores de polimerasas virales de arn.
NO20065582L (no)	2006-12-04	(1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer
WO2005051318A3 (en)	2006-08-31	Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
BR0208987A (pt)	2004-04-27	Composto tricìclicos úteis como inibidores de transcriptase reserva de hiv
TW200710091A (en)	2007-03-16	(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
SG145742A1 (en)	2008-09-29	Entry inhibitors of the hiv virus
MXPA03000434A (es)	2003-06-24	Compuestos de 2-piridona triciclicos utiles como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).
NO20076389L (no)	2008-02-20	Sammenstninger og metoder for behandling av HIV-infeksjon med cupredoxin og cytokrom C